Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

NCT02073448 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

417

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: GK530G
DRUG: CD0271
DRUG: CD1579

Sponsor

Galderma R&D